
Nikola Mićić
Areas of Expertise
Corporate
Employment
Commercial Law
Education
LLB – Faculty of Law, University of Belgrade (2023)

Corporate
Employment
Commercial Law
LLB – Faculty of Law, University of Belgrade (2023)
Nikola is an associate with a primary focus on corporate and M&A, employment and commercial matters.
Nikola joined Radovanović Stojanović & Partners after graduating from the University of Belgrade, where he obtained his LLB degree.
Serbian, English, German

On 12 December 2025, the Law on the Exchange of Data, Documents and Notifications in Cases of Temporary Incapacity for Work Using the “e-Sick Leave – Employer” Software Solution (“Law”), entered into force.


On 28 April 2023, the National Assembly of the Republic of Serbia adopted a new Law on Occupational Health and Safety ("Law"). Although the Law formally entered into force on 7 May 2023, its full application was postponed until 7 May 2025, providing employers with a transitional period to harmonize their operations with the new requirements.
Nikola Cincović
The Serbian Commission for Protection of Competition (CPC) has denied Roche and ADOC's request to extend their exclusive distribution agreement exemption, marking a significant shift in regulatory oversight. This July 2024 decision affects the distribution of three crucial pharmaceuticals: Kadcyla, Perjeta, and Tecentriq.
Raško Radovanović
Radovanović Stojanović & Partners advised British American Tobacco on a sidestream merger of its Serbian subsidiaries British American Tobacco South-East Europe doo Beograd (as the transferring entity) and British American Tobacco Vranje ad (as the surviving entity).
RS Partners